Ramucirumab as second line therapy in metastatic gastric cancer (MGC): results of the Italian compassionate-use named patients. The RAMoss study

Authors :: Angelica Petrillo
Silvia Bozzarelli
Caterina Vivaldi
Salvatore Galdy
M. Squadroni
Alessandro Bittoni
Elisa Giommoni
Katia Bencardino
M. Di Bartolomeo
Monica Niger
F. De Vita
M. Spada
Giuseppe Tirino
E. Menatti
Ilaria Proserpio
A. Zaniboni
G. Tomasello
Andrea Spallanzani
Teodoro Sava
Tiziana Latiano
Source :: Annals of Oncology. 27:iv17
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
medicine.medical_specialty
Second-line therapy
Second line treatment
business.industry
Internal medicine
medicine
Compassionate Use
Hematology
business
Ramucirumab
Metastatic gastric cancer

Full Text Access

Tools